Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

recruiting125%
active_not_recruiting125%
completed250%

Recent Activity

2 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers

NCT02596191
completed

Muscle OXPHOS and Nutrient Homeostasis

NCT02920671
recruiting

The Neuroimage Study of the Neuromuscular Disorders.

NCT05048862
completednot_applicable

Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy

NCT02391831

Clinical Trials (4)

Showing 4 of 4 trials
NCT02596191Not Applicable

Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers

Active Not Recruiting
NCT02920671

Muscle OXPHOS and Nutrient Homeostasis

Completed
NCT05048862

The Neuroimage Study of the Neuromuscular Disorders.

Recruiting
NCT02391831Not Applicable

Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4